Alterations in homologous recombination repair genes in prostate

Improving Patient Access to Homologous Recombination Deficiency Testing for Precision Oncology

Genomic Testing for Advanced Prostate Cancer: Ready for Prime Time?

Molecular Genetics of Prostate Cancer and Role of Genomic Testing - Surgical Pathology Clinics

Genetic testing for homologous recombination repair (HRR) in metastatic castration-resistant prostate cancer (mCRPC): challenges and solutions

Real-world genetic testing patterns in metastatic castration-resistant prostate cancer

PARP inhibitor applicability

Clinical implications of homologous recombination repair mutations in prostate cancer - Cresta Morgado - 2022 - The Prostate - Wiley Online Library

Full article: Exploiting defects in homologous recombination repair for metastatic, castration-resistant prostate cancer

Prostate cancer and PARP inhibitors: progress and challenges, Journal of Hematology & Oncology

PDF] Defects in homologous recombination repair behind the human diseases: FA and HBOC.

Homologous recombination

Genetic aberrations in DNA repair pathways: a cornerstone of precision oncology in prostate cancer

Genetic aberrations in DNA repair pathways: a cornerstone of precision oncology in prostate cancer

Homologous Recombination Repair Deficiency: An Overview for Pathologists - Modern Pathology

ASCO 2022: Gene-by-Gene Analysis in the MAGNITUDE Study of Niraparib (NIRA) with Abiraterone Acetate and Prednisone (AAP) in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Homologous Recombination Repair (HRR) Gene Alterations.